Operating profit before deduction of amortization: Savara (SVRA)
Savara Inc. employs an asset-light strategy, outsourcing the production of inhalation agents to third-party contractors to ensure supply stability. EBITDA dynamics confirm the company's status as a trusted developer of therapies for rare lung pathologies, with the metric currently standing at 0.00. The business is currently focused on deploying its commercial network and identifying global distributors to launch its primary drug to market.
Savara (SVRA) - metric breakdowns and financial figures
- stock value and consensus price forecast:
- company stock exchange capitalization indicators:
- shareholders' equity book value data:
- debt level and financial liquidity data:
- earnings and multiples data:
SVRA - Net Profit|Projected Future Earnings Savara Inc.|SVRA - Price to Earnings Ratio|Future Price to Earnings Multiple savarapharma.com|SVRA - PEG Multiple|EV/EBITDA Multiple Savara|SVRA - Operating profit before deduction of amortization|Earnings per share for the trailing year Savara|SVRA - Net earnings per share (EPS TTM)|Year-over-year net earnings per share change for the last twelve months savarapharma.com|SVRA - Earnings per share growth in current year|Projected earnings per share growth rate for next year Savara Inc.
Analysis of all company metrics:SVRA Savara Pharma
This indicator measures the actual cash inflow from core operations before deducting financial and tax obligations. For Savara Inc. (SVRA), this parameter reflects the funding efficiency of inhalation drug development. Analyzing the absolute cash result of operations allows for an assessment of how global diversification of clinical trials impacts operational stability. The rising curve confirms business scaling, although purchasing the asset at peak values increases the risk of a correction.
Who Savara Inc. competes with
Operating income before deduction of amortization argenx BVBA (ARGX)|BNTX - Profit before payment of interest, taxes and amortization|Abivax S.A. (ABVX) - Operating profit before deduction of amortization|ADMA Biologics, Inc. (ADMA) - Profit before payment of interest, taxes and amortization|Operating profit before deduction of amortization Protagonist Therapeutics, Inc.|Operating profit before deduction of amortization IMVT|Operating profit EBITDA Kiniksa Corp|Profit before payment of interest, taxes and amortization Grifols, S.A. (GRFS)|adaptivebiotech.com - Operating profit before amortization|Operating profit EBITDA CLDX (Celldex Therapeutics, Inc.)|Aurinia Pharmaceuticals Inc (AUPH) - Profit before interest, taxes and amortization|BCRX - Profit before payment of interest, taxes and amortization|Operating income before deduction of amortization Vera Corp VERA|DNTH: Operating profit EBITDA|pharvaris.com (PHVS) - Operating profit EBITDA|Operating profit before deduction of amortization ABCL|Profit before payment of interest, taxes and amortization TRML|Operating profit EBITDA PGEN|Operating profit EBITDA Pharming Corp (PHAR)|Profit before payment of interest, taxes and amortization Nektar Therapeutics NKTR|Income before deduction of interest, taxes and amortization UPB|Zenas Biopharma - Operating profit EBITDA|IMNM - Operating profit EBITDA|GOSS (Gossamer Corp) - Operating profit before deduction of amortization|KalVista Corp - Income before deduction of interest, taxes and amortization|SEPN (Septerna Inc) - Operating profit EBITDA|pieris.com (PVLA) - Operating income before deduction of amortization|Profit before payment of interest, taxes and amortization Rigel Pharmaceuticals, Inc. (RIGL)|AnaptysBio Inc - Operating profit before amortization|Operating profit EBITDA ATXS (Astria Pharma)|ENGN - Operating profit before deduction of amortization|RAPT: Operating profit before deduction of amortization|Operating income before deduction of amortization Aerovate Therapeutics Inc JBIO|Aclaris Therapeutics, Inc. (ACRS) - Profit before payment of interest, taxes and amortization|KYTX - Operating income before deduction of amortization|Operating profit before deduction of amortization TLSA|Profit before payment of interest, taxes and amortization CABA|Profit before payment of interest, taxes and amortization Ventyx Biosciences (VTYX)|THTX (theratech.com) - Income before deduction of interest, taxes and amortization|Operating profit EBITDA AVTX (Avalo Therapeutics)|Operating profit EBITDA Eledon Pharmaceuticals Inc. ELDN|AGEN - Profit before payment of interest, taxes and amortization|Profit before deduction of interest, taxes, depreciation and amortization CLYM|ZURA: Operating profit EBITDA|atyrpharma.com - Income before deduction of interest, taxes and amortization|ADAG (Adagene Inc) - Operating profit EBITDA|Operating profit EBITDA Ikena Oncology, Inc.|Profit before payment of interest, taxes and amortization Shattuck Labs, Inc. (STTK)|EQ (equilliumbio.com) - Income before deduction of interest, taxes and amortization|Profit before payment of interest, taxes and amortization Connect Biopharma Holdings Limited CNTB|IMUX - Operating profit before deduction of amortization|Atara Biotherapeutics Inc - Operating profit EBITDA|IFRX - Operating profit EBITDA|XFOR (X4 Pharma) - Operating profit before deduction of amortization|Adicet Bio, Inc. - Income before deduction of interest, taxes and amortization|CELU (Celularity Inc) - Operating profit EBITDA|inmunebio.com (INMB) - Operating income before deduction of amortization|Profit before payment of interest, taxes and amortization Barinthus Biotherapeutics plc (BRNS)|Operating profit before deduction of amortization Kezar Life Sciences Inc. KZR|Profit before payment of interest, taxes and amortization SAB Biotherapeutics, Inc SABS|AKTX - Operating profit before deduction of amortization|ENLV: Operating profit before deduction of amortization|QTTB - Operating profit EBITDA|GeoVax (GOVX) - Profit before payment of interest, taxes and amortization|Operating profit before amortization EDSA|IBIO (iBio Corp) - Operating profit EBITDA|Profit before interest, taxes and amortization Carisma Tx CARM|Profit before payment of interest, taxes and amortization XTL Biopharmaceuticals (XTLB)|Operating income before deduction of amortization boltbio.com|Operating profit EBITDA HCWB (HCW Biologics)|Operating profit EBITDA Aptevo Therapeutics, Inc. APVO|AIM: Operating profit before deduction of amortization|ADTX: Profit before payment of interest, taxes and amortization|GRI: Operating profit EBITDA|xortx.com (XRTX) - Operating profit EBITDA|Profit before payment of interest, taxes and amortization Vyome Holdings|REVB: Income before deduction of interest, taxes and amortization|Operating profit EBITDA INDP|Operating profit EBITDA BiondVax Pharmaceuticals (SCNI)|CalciMedica - Operating profit before deduction of amortization|Income before deduction of interest, taxes and amortization AFMD|Allakos Therapeutics - Operating profit EBITDA|Operating income before deduction of amortization HOOKIPA Pharma Inc. HOOK|igmbio.com (IGMS) - Profit before payment of interest, taxes and amortization|Operating profit before amortization ITOS|OCEA (Ocean Biomedical, Inc.) - Operating profit EBITDA|Operating profit before deduction of amortization tcbiopharm.com (TCBP)|Operating profit before deduction of amortization THRD (Third Harmonic Bio, Inc.)
